Aromatase P450 (CYP19) is an enzyme catalysing the conversion of androgens into oestrogens. We generated mice lacking aromatase activity (ArKO) by targeted disruption of Cyp19 and report the characteristic features of the ArKO ovaries and uteri as revealed by histological and biochemical analyses. ArKO females were totally infertile but there were as many developing follicles in their ovaries at 8 weeks of age as in wild-type ovaries. Nevertheless, no typical corpus luteum was observed in the ArKO ovaries. Electron microscopy revealed the presence of well-developed smooth endoplasmic reticulum, few lipid droplets and mitochondria with less organized tubular structures in the ArKO luteinized interstitial cells. These ultrastructural features were different from those of the wild-type interstitial cells, where there are many lipid droplets and mitochondria with well-developed tubular structures, characteristic of steroid-producing cells. When ArKO mice were supplemented with 17beta-oestradiol (E(2); 15 microg/mouse) every fourth day from 4 weeks of age for 1 month, increased numbers of follicles were observed in the ovaries as compared with those of untreated ArKO mice, although no typical corpus luteum was detectable. Ultrastructural analysis revealed the disappearance of the accumulated smooth endoplasmic reticulum in the luteinized interstitial cells after E(2 )supplementation. Transcripts of pro-apoptotic genes such as p53 and Bax genes were markedly elevated in the ArKO ovaries as compared with those of wild-type mice. Although E(2) supplementation did not cause suppression of the elevated expression of p53 and Bax mRNAs, it caused marked enhancement of expression levels of lactoferrin and progesterone receptor mRNAs in the uteri as well as increases in uterine wet weight. At 8 months of age, ArKO mice developed haemorrhages in the ovaries, in which follicles were nearly depleted, while age-matched wild-type females still had many ovarian follicles. Furthermore, macrophage-like cells were occasionally observed in the ArKO ovarian follicles. These results suggested that targeted disruption of Cyp19 caused anovulation and precocious depletion of ovarian follicles. Additionally, analysis of mice supplemented with E(2) demonstrated that E(2) apparently supports development of ovarian follicles, although it did not restore the defect in ovulation.

This article has been cited by other articles:

				K. Toda, T. Okada, Y. Hayashi, and T. Saibara Preserved tissue structure of efferent ductules in aromatase-deficient mice J. Endocrinol., October 1, 2008; 199(1): 137 - 146. [Abstract] [Full Text] [PDF]

				L. Wang, H. Dankert, P. Perona, and D. J. Anderson Inaugural Article: A common genetic target for environmental and heritable influences on aggressiveness in Drosophila PNAS, April 15, 2008; 105(15): 5657 - 5663. [Abstract] [Full Text] [PDF]

				C. De Mees, J.-F. Laes, J. Bakker, J. Smitz, B. Hennuy, P. Van Vooren, P. Gabant, J. Szpirer, and C. Szpirer Alpha-Fetoprotein Controls Female Fertility and Prenatal Development of the Gonadotropin-Releasing Hormone Pathway through an Antiestrogenic Action. Mol. Cell. Biol., March 1, 2006; 26(5): 2012 - 2018. [Abstract] [Full Text] [PDF]

				T. K. Woodruff and K. E. Mayo To {beta} or Not To {beta}: Estrogen Receptors and Ovarian Function Endocrinology, August 1, 2005; 146(8): 3244 - 3246. [Full Text] [PDF]

				K. L. Britt, P. G. Stanton, M. Misso, E. R. Simpson, and J. K. Findlay The Effects of Estrogen on the Expression of Genes Underlying the Differentiation of Somatic Cells in the Murine Gonad Endocrinology, August 1, 2004; 145(8): 3950 - 3960. [Abstract] [Full Text] [PDF]

				K. Huynh, G. Jones, G. Thouas, K. L. Britt, E. R. Simpson, and M. E.E. Jones Estrogen Is Not Directly Required for Oocyte Developmental Competence Biol Reprod, May 1, 2004; 70(5): 1263 - 1269. [Abstract] [Full Text] [PDF]

				K. N. Hewitt, K. Pratis, M. E. E. Jones, and E. R. Simpson Estrogen Replacement Reverses the Hepatic Steatosis Phenotype in the Male Aromatase Knockout Mouse Endocrinology, April 1, 2004; 145(4): 1842 - 1848. [Abstract] [Full Text] [PDF]

				K. Toda, Y. Okada, M. Zubair, K.-i. Morohashi, T. Saibara, and T. Okada Aromatase-Knockout Mouse Carrying an Estrogen-Inducible Enhanced Green Fluorescent Protein Gene Facilitates Detection of Estrogen Actions in Vivo Endocrinology, April 1, 2004; 145(4): 1880 - 1888. [Abstract] [Full Text] [PDF]

				M. G. Goodin and R. J. Rosengren Epigallocatechin Gallate Modulates CYP450 Isoforms in the Female Swiss-Webster Mouse Toxicol. Sci., December 1, 2003; 76(2): 262 - 270. [Abstract] [Full Text] [PDF]

				C. J. Henderson and C. R. Wolf Transgenic Analysis of Human Drug-Metabolizing Enzymes: Preclinical Drug Development and Toxicology Mol. Interv., September 1, 2003; 3(6): 331 - 343. [Abstract] [Full Text] [PDF]

				K. Toda, T. Okada, C. Miyaura, and T. Saibara Fenofibrate, a ligand for PPAR{alpha}, inhibits aromatase cytochrome P450 expression in the ovary of mouse J. Lipid Res., February 1, 2003; 44(2): 265 - 270. [Abstract] [Full Text] [PDF]

				B. C. J. van der Eerden, J. van de Ven, C. W. G. M. Lowik, J. M. Wit, and M. Karperien Sex Steroid Metabolism in the Tibial Growth Plate of the Rat Endocrinology, October 1, 2002; 143(10): 4048 - 4055. [Abstract] [Full Text] [PDF]

				N. C. Zachos, R. B. Billiar, E. D. Albrecht, and G. J. Pepe Developmental Regulation of Baboon Fetal Ovarian Maturation by Estrogen Biol Reprod, October 1, 2002; 67(4): 1148 - 1156. [Abstract] [Full Text] [PDF]

				D. Tsavachidou and M. N. Liebman Modeling and Simulation of Pathways in Menopause J. Am. Med. Inform. Assoc., September 1, 2002; 9(5): 461 - 471. [Abstract] [Full Text] [PDF]

				K. L. BRITT, J. KERR, L. O'DONNELL, M. E. E. JONES, A. E. DRUMMOND, S. R. DAVIS, E. R. SIMPSON, and J. K. FINDLAY Estrogen regulates development of the somatic cell phenotype in the eutherian ovary FASEB J, September 1, 2002; 16(11): 1389 - 1397. [Abstract] [Full Text] [PDF]